Home » Jin Sung-kyu only finished the vaccine 17 days ago and was diagnosed with asymptomatic infection | INFINITE | COVID-19 | Wuhan pneumonia

Jin Sung-kyu only finished the vaccine 17 days ago and was diagnosed with asymptomatic infection | INFINITE | COVID-19 | Wuhan pneumonia

by admin

[Epoch Times, June 27, 2021](The Epoch Times reporter Zeng Weixin compiled a report) Double H TNE, a brokerage company owned by popular Korean singer Kim Sung-kyu, announced today (27th) that it will receive regular quarantine and be vaccinated on June 10 Jin Shenggui received a notice on the morning of the 27th that the quarantine result of the Chinese Communist Party virus (Wuhan pneumonia/COVID-19) was positive.

Double H TNE stated that Jin Sung-kyu received regular quarantine every week for the preparation of the musical “Gwanghwamun Sonata”. He was vaccinated with Johnson’s vaccine on the 10th of this month and still received a positive judgment during the quarantine. Kim Sung-kyu has no symptoms and no abnormal physical condition.

The company also stated that it has completed inspections and other necessary measures for staff who have overlapping lines with Jin Sung-kyu or have contact with him. Jin Sung-gyu will suspend all activities and follow the instructions of the epidemic prevention authority, related staff and those in close contact with him. Company personnel will be quarantined separately.

At the end of the statement, Double H TNE stated that it will actively cooperate with the government’s policy, strive to do a good job in epidemic prevention management and pay more attention to the management of artists. At the same time, it apologizes for the worries from all walks of life caused by this incident.

Editor in charge: Liang Mengzhu

.

See also  Ram Unveils Stunning 2024 Spring and Summer Collection in Shanghai, Embracing 'Shanghai Style' and Artistic Beauty

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy